RETINALGENIX TECHNOLOGIES INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
RETINALGENIX TECHNOLOGIES INC. (RTGN) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $3.00 per share for the 12-month period ending 2024-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-04-15
- RETINALGENIX TECHNOLOGIES INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2022-03-31 was $0.53.
- RETINALGENIX TECHNOLOGIES INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $3.00, a 0.00% change from fiscal 2023.
- RETINALGENIX TECHNOLOGIES INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $3.00, a 200.00% increase from fiscal 2022.
- RETINALGENIX TECHNOLOGIES INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $1.00, a 0.00% change from fiscal 2021.
- RETINALGENIX TECHNOLOGIES INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2021 was $1.00.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2024-12-31 | $3.00 10-K · filed 2026-04-15 | |||
| 2024-09-30 | $3.00 10-Q · filed 2024-11-18 | |||
| 2024-06-30 | $3.00 10-Q · filed 2024-08-19 | |||
| 2023-12-31 | $3.00 10-K · filed 2025-03-31 | |||
| 2023-09-30 | $3.00 10-Q · filed 2023-11-14 | |||
| 2022-12-31 | $1.00 10-K · filed 2024-04-01 | |||
| 2022-09-30 | $1.00 10-Q · filed 2022-11-17 | |||
| 2022-06-30 | $0.53 10-Q · filed 2022-08-19 | |||
| 2022-03-31 | $0.53 10-Q/A · filed 2022-05-16 | |||
| 2021-12-31 | $1.00 10-K/A · filed 2023-06-15 | |||
| 2021-09-30 | $1.00 10-Q · filed 2021-11-22 |